Our Team

Board of Directors

Thomas Oxley, MD, PhD Portrait

Thomas Oxley, MD, PhD

CEO and Founder
Founding CEO and Associate Professor Thomas Oxley is a neuro-interventionalist with expertise in neurology, internal medicine, and stroke. He was awarded his PhD in Neural Engineering from the University of Melbourne, and completed his endovascular neurosurgery fellowship at Mount Sinai Hospital under Dr.’s Mocco and Berenstein. In 2018, he was the winner of the Advance Life Sciences Award. He is a Co-Head of the Vascular Bionics Laboratory at the University of Melbourne and the Director of Innovation Strategy for the Department of Neurosurgery at the Mount Sinai Health System. His work has been published in major journals including Nature Biotechnology and New England Journal of Medicinewith over 4000 citations. He has presented his research at over numerous conferences, including the TedX talk in Sydney in 2018.
Nicholas Opie, PhD Portrait

Nicholas Opie, PhD

CTO and Founder

Founding CTO and Associate Professor Nicholas Opie is a biomedical engineer with experience in neural prostheses and medical bionics. He was awarded his Bachelor of Science and Bachelor of Electrical and Computer Systems Engineering with Honours at Monash University, his PhD in retinal neuroprostheses at Melbourne University, and his MBA at Melbourne Business School. He is a Westpac Bicentennial Fellow and a Co-Head of the Vascular Bionics Laboratory at the University of Melbourne. He has published over 40 peer-reviewed scientific papers in journals including Nature Biomedical Engineering and Nature Biotechnology, has presented his research at more than 70 local and international conferences and has over 20 patent filings on the Stentrode™ technology and it’s applications.

Martin Dieck Portrait

Martin Dieck

Chairman

An experienced corporate leader with expertise in developing novel neurovascular solutions Martin Dieck, serves as chairman of Synchron. He received his MBA from the University of California, Berkley and his Bachelor’s Degree in Biology from Willamette University. Prior to being appointed the Chairman of Syncrhon, he led Lazarus Effect Inc., a novel vascular interventional device, Nfocus Neuromedical, Inc., a developer of neurovascular intravascular devices, and Concentric Medical, Inc., which developed the first cleared thrombectomy device to treat large vessel ischemic stroke, which were acquired by Medtronic, Covidien and Stryker, respectively.  Dieck also serves as a chairman for Serenity Medical, a managing member for Neuro Technology Investors LLC and executive chairman for Cerebrotech Medical.

Rahul Sharma, MBBS Portrait

Rahul Sharma, MBBS

Head of Business Development

Dr Rahul P. Sharma, MBBS, FRACP is the Director of Structural Interventions at Stanford Healthcare and Clinical Assistant Professor of Medicine at Stanford University.

Dr Sharma graduated from Monash University and completed his medicine and cardiology training at the Alfred Hospital in Melbourne, Australia. He completed an advanced interventional and structural fellowship at Cedars Sinai Medical Center in Los Angeles, California in 2015 before joining Cedars Sinai as Clinical Faculty, Director of the Structural Imaging Core Laboratory and Associate Director of Interventional Cardiology Research until 2019, before joining Stanford Healthcare.

Dr Sharma is an Interventional Cardiologist with specialized clinical and research interests in structural heart disease, particularly transcatheter valve therapy. He has a large volume of expertise in transcatheter aortic, mitral and tricuspid replacement, percutaneous mitral valve repair, left atrial appendage occlusion, PFO/ASD/VSD closure, alcohol septal ablation and cerebral protection. He also has expertise in CT imaging for structural heart disease. He is a clinical investigator in ongoing national multi-center research studies and clinical trials and has co-authored numerous peer reviewed, scientific articles and book chapters. Dr Sharma also serves as a national and international clinical proctor for transcatheter aortic and mitral valve implantation and percutaneous mitral valve repair and speaks regularly at major national and international cardiology meetings.